<SEC-DOCUMENT>0000950170-24-127964.txt : 20241118
<SEC-HEADER>0000950170-24-127964.hdr.sgml : 20241118
<ACCEPTANCE-DATETIME>20241118161511
ACCESSION NUMBER:		0000950170-24-127964
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20241114
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241118
DATE AS OF CHANGE:		20241118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Terns Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001831363
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39926
		FILM NUMBER:		241471675

	BUSINESS ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-525-5535 EXT.101

	MAIL ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tern-20241114.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-11-18T16:08:23.0600+00:00 -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:tern="http://www.ternspharma.com/20241114" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;line-height: 1;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_35ad777e-8b4b-4f74-9ce5-1ad57748c27a" name="dei:EntityCentralIndexKey" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624">0001831363</ix:nonNumeric><ix:nonNumeric id="F_41a4be09-6a6f-4476-84b4-dfb1645f94b2" name="dei:AmendmentFlag" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="tern-20241114.xsd"/></ix:references><ix:resources><xbrli:context id="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001831363</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-14</xbrli:startDate><xbrli:endDate>2024-11-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d9d9d3cb-966a-4e43-92de-ada75590e65b" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_dbd7e313-c13b-4d12-aec9-3965dfcf61f8" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">November 14, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b90c8090-f8e2-42bf-81e7-f55ce2757df2" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Terns Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:20%;box-sizing:content-box;"/>
    <td style="width:18%;box-sizing:content-box;"/>
    <td style="width:41%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_70cbbacf-d787-40bb-803f-c171e05536cc" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cd786709-c362-4a96-9081-1f30f1a10ae8" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">001-39926</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_3e50b778-10d1-4ec8-b4cd-7bc2080dbb75" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">98-1448275</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5ca26a61-d15f-47c6-8d95-a24c131002d2" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1065 East Hillsdale Blvd.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5afdbad6-1af0-4e39-8ebd-685169626166" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Suite 100</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_269510e4-adcb-4bfb-bb68-24b18ac98812" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Foster City</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_eba964f7-2732-4962-92b4-8cbf1b605e88" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">California</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_444e97b8-947f-40d8-b106-3b41617d9658" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">94404</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_7ba8799d-7e2a-4310-a068-d95ca8ee7364" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(650)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_54b2c2ee-d482-4858-a764-796fdcca2915" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">525-5535</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6058554f-25f4-4a95-b6f8-0e15720d4027" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Not Applicable</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68445042-42ab-4466-9cff-c6ac5018aa6a" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cea236c7-d9cb-4a67-9fc8-8589da270418" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_debe4bb7-8117-41db-a328-77dd38fe322d" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a01903ff-a599-4b9f-9c2b-740857f7e77b" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_12e9ccf6-dea3-4f4d-a2d4-073a9ee2c7df" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_58ec0c33-cd4b-4d19-b171-774ae6eeb5f3" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">TERN</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6c931630-d568-4844-a0ed-923b6484ac71" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_106cd42a-4954-4884-8366-31f95e6cfc09" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_434d00bf-20b7-49b6-9dc0-19e6f7e09c01" contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 14, 2024, Ann Taylor notified Terns Pharmaceuticals, Inc. (the &#8220;Company&#8221;) of her resignation from the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), effective as of November 18, 2024. The decision by Dr. Taylor to resign from the Board was not due to a disagreement on any matter related to the Company&#8217;s operations, policies or practices.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 15, 2024, the Board appointed and elected Heather Turner as a member of the Board, effective as of November 18, 2024. Ms. Turner was appointed as a Class I director to serve in accordance with the Company&#8217;s amended and restated bylaws until the 2025 annual meeting of stockholders and thereafter until her successor is duly elected and qualified or until her earlier death, resignation or removal. Ms. Turner was also appointed to serve as a member of the Audit Committee of the Board.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">There is no arrangement or understanding between Ms. Turner and any other person pursuant to which she was appointed as a director of the Company, and there are no family relationships between Ms. Turner and any of the Company&#8217;s directors or executive officers. There are no transactions to which the Company is a party and in which Ms. Turner has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Ms. Turner is eligible to receive cash compensation and equity awards pursuant to the Company&#8217;s second amended and restated compensation program for non-employee directors, which is described in more detail in the Company&#8217;s proxy statement filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on April 25, 2024. In connection with her appointment, Ms. Turner and the Company will also enter into the Company&#8217;s standard form of indemnification agreement, a copy of which is included as Exhibit 10.12 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 14, 2024.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 7.01. Regulation FD Disclosure.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 18, 2024, the Company issued a press release announcing the appointment of Ms. Turner to the Board and the resignation of Dr. Taylor. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01. Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit<br/>No.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="tern-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release issued by Terns Pharmaceuticals, Inc. on November 18, 2024.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:46%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">TERNS PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">November 18, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Amy Burroughs</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Amy Burroughs<br/>Chief Executive Officer<br/></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tern-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;line-height: 1;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.9in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img52906712_0.jpg" alt="img52906712_0.jpg" style="width:155px;height:81px;"></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experience</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">FOSTER CITY, Calif., November 18, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (&#x201c;Terns&#x201d; or the &#x201c;Company&#x201d;) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Heather Turner, J.D., former Chief Executive Officer at Carmot Therapeutics, Inc., to the Company&#x2019;s Board of Directors, effective immediately. In conjunction with Ms. Turner&#x2019;s appointment, Ann E. Taylor, M.D., is stepping down from the Board of Directors following more than three years of service.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;It is my pleasure to welcome Heather to the Terns Board, and I am confident she will be a valued thought partner. Heather brings relevant sector expertise in obesity and oncology and a deep understanding of the development of therapeutic products from research and development through to commercialization. We look forward to her insights and contribution to the strategic decisions that will strengthen and drive Terns&#x2019; further growth,&#x201d; said Amy Burroughs, chief executive officer of Terns. &#x201c;We thank Ann for her many contributions to Terns over the last three years as we have progressed innovative programs from research to the clinic.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#x201c;I am delighted to be joining the Terns&#x2019; team as we advance a robust clinical development pipeline with the potential to transform patient care across serious metabolic diseases and oncology,&#x201d; stated Ms. Turner. &#x201c;I am excited to work with Terns&#x2019; talented leadership and Board to advance their novel, small molecule product candidates through clinical development to bring differentiated, new medicines to the patients who need them.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Ms. Turner is a seasoned biotechnology executive with 25 years of experience across a range of therapeutic areas and stages of company development. Most recently, she served as Chief Executive Officer of Carmot Therapeutics, where she led the execution of a dual track IPO/strategic transaction process, which ultimately resulted in the acquisition of Carmot by Roche for $3.1 billion. Prior to that, she was Chief Legal Officer at Lyell Immunopharma. Before that, Ms. Turner held General Counsel leadership roles at Sangamo Therapeutics, Atara Biotherapeutics, Orexigen Therapeutics, and Conor Medsystems. Ms. Turner began her career as an attorney in the Business Department of Cooley LLP. She earned her J.D. at the University of California, Los Angeles &#x2013; School of Law and her B.S. in Environmental Studies at the University of California, Santa Barbara.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">About Terns Pharmaceuticals</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns&#x2019; pipeline contains three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-&#x3b2; agonist, and a preclinical GIPR modulator discovery effort, prioritizing a GIPR antagonist nomination candidate. For more information, please visit: </font><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">www.ternspharma.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">.</font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.9in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.9in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Cautionary Note Regarding Forward-Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">This press release contains forward-looking statements about the Company within the meaning of the federal securities laws, including those related to expectations, timing and potential results of the clinical trials and other development activities of the Company and its partners; the potential indications to be targeted by the Company with its small-molecule product candidates; the therapeutic potential of the Company&#x2019;s small-molecule product candidates; the potential for the mechanisms of action of the Company&#x2019;s product candidates to be therapeutic targets for their targeted indications; the potential utility and progress of the Company&#x2019;s product candidates in their targeted indications, including the clinical utility of the data from and the endpoints used in the Company&#x2019;s clinical trials; the Company&#x2019;s clinical development plans and activities, including the results of any interactions with regulatory authorities on its programs; the Company&#x2019;s expectations regarding the profile of its product candidates, including efficacy, tolerability, safety, metabolic stability and pharmacokinetic profile and potential differentiation as compared to other products or product candidates; the Company&#x2019;s plans for and ability to continue to execute on its current development strategy, including potential combinations involving multiple product candidates; the potential commercialization of the Company&#x2019;s product candidates; the Company&#x2019;s plans and expectations around the addition of key personnel; and the Company&#x2019;s expectations with regard to its cash runway and sufficiency of its cash resources. All statements other than statements of historical facts contained in this press release, including statements regarding the Company&#x2019;s strategy, future financial condition, future operations, future trial results, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#x201c;aim,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;assume,&#x201d; &#x201c;believe,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;continue,&#x201d; &#x201c;could,&#x201d; &#x201c;design,&#x201d; &#x201c;due,&#x201d; &#x201c;estimate,&#x201d; &#x201c;expect,&#x201d; &#x201c;goal,&#x201d; &#x201c;intend,&#x201d; &#x201c;may,&#x201d; &#x201c;objective,&#x201d; &#x201c;plan,&#x201d; &#x201c;positioned,&#x201d; &#x201c;potential,&#x201d; &#x201c;predict,&#x201d; &#x201c;seek,&#x201d; &#x201c;should,&#x201d; &#x201c;target,&#x201d; &#x201c;will,&#x201d; &#x201c;would&#x201d; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results and the implementation of the Company&#x2019;s plans to vary materially, including the risks associated with the initiation, cost, timing, progress, results and utility of the Company&#x2019;s current and future research and development activities and preclinical studies and clinical trials. These risks are not exhaustive. For a detailed discussion of the risk factors that could affect the Company&#x2019;s actual results, please refer to the risk factors identified in the Company&#x2019;s SEC reports, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2023. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Contacts for Terns</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Investors</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Justin Ng</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">investors@ternspharma.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Media</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Jenna Urban</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">Berry &amp; Company Public Relations</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;text-decoration:underline;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">media@ternspharma.com</font></p>
  <div class="page-node-content"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.9in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img52906712_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img52906712_0.jpg
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MX9#_V@ , P$  A$#$0   ;_
M
M
M
M
M
M                          #I.77%'8ZB'6STL0-GIO.>[%L,TTDM_C4S
MY'SZ                         !YUNXU^?OSL\?*[+HRNTQ\KG=60
M(YYNL@[MM#![;:&&^STN'=O0 !=?%9U<S&)L
M !Y]N8Y7+=OFN)ED4]_.?6/IQY=ET979]&5V71E=ECY/9=&5V71E=ICY?88^
M7VG3D=GCY79=&5V?1E>N1J93"K&ZHY2^OX\RV!\3J[N)U]O=8^7(/6;GL<?+
MSS12GT_3R                          >)R2'5TW%YYC+853<S(Q/[]^
M  <'JR.=VXX $I:]MGG=7?$RQZ? X&/E^BPZPI^U#Z F?"++YO#L
M                  'B.]B]?MH4E$JRJ;Y^UT7W[>D #&<':9-G:L  6 TS
MZ+K^N;SI^>//.8W,;$Z3](S!@-J_3YR                            &
M&Y>!"&=UA#RR*=\IFE;]OFZ[]\N'PX=GD\>F'K\DA8  L IGT5!BVZ$G]2WH
MZ=53WQSNKO                               \TV6FBW-*X\&G%:1EW4
M>C'C;"1]A4^ !ZA'Y7852WH_WR&V'G.IWX
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M/0NR!IUV92UW\4G=IL>ENG)9M*VNQZ774Q6<QLS]7JU6!5&Q]![,L'TTC
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M#$"1Y#DF*=\1T.>32^@              !CV;K:&/8/Y\WJ^1??F9ZO>
M   "MOXF:0R.28J=^8T9N>$?'OGUA7QE_P!<LRX\"^/7/K&B;9X6>;G#/0CP
MSX['ZSX[4\1+2OH               8]FZVJ;T3Y&MZ\T^RP       /@?<^
M!\CDGP/L<8^A^3[GS.*<XX1S#KCM3Y'\.(<L^IQ3Y'W/F<X
M  &/9NMC//*MES6UR                                     #K>_%_
M+YVG1E@
M
M
M
M
M
M                        #__:  @! 0 !!0+_ !KKW)N:R7O/N+&.GOJW
M0AIYZE,HNET>=<KH3<>=49*U04:4>5\54RV-(SPS")CM:21X5K.[3>K*4PK^
MRD.1B&*I!GG)P1/^4,\NXEQ<@7'[/2[D50H^+/\ %V23)Y5B1\9JO_J^@1"
M("]<7<#X]%4"428J@327 L&?3(-K9)F]K6RI/+5_Z[-P4',<R#<&:I:&X,WR
M6U SD\VLR9I95IA9J9<GF<LB,6$9D> **',,0*1"><%*1M#UA%G=09=A(J#E
MB!W"R3*.207Q238_C4IM)<52N/T$\ K^P4B[I.SC.;GQYSS&UJ$DKU,4 !4=
MA<OF HU@Z-M=TZ9.D)^+2?'L6EEI'A:4L]'''HE 3 #VG S;FX^=XMJ]^RF"
M)R"5GQ7#; RT$(0!^-/,>9)"G?\  #>9=Y@<[C5%KBAU85KZ&&!* J57&;M3
M$/)\3H&]<Z*8IA@@JDR9.C(^/O4.BTBISP,Q&TX88F:*GR%SE%2OQTY^S#&7
M\@DLOA3I-I"Q1MGC:7Y%?"23VC9P@R=TO9G62(SCHK^F\6U_3>+:_IO%M?TW
MBVOZ;Q;3)U!XZD#O4XRY#L>N']-XMK^F\6U_3>+:_IO%M0?+D.R$X4]]0>.H
M^[_TWBVOZ;Q;7]-XMI%U(XI5GM;NUOB+17U(XR1*H-E6'9#/U5]2.,D2J#S^
M/9";])3E_'D.-_IO%M-?43BIS4)5:5>G]^=_M6P$(ABBK,%@C^SU=?;MG$_[
M+KJS]9['29ZSK+'[+V(!D218[>(O)&V7,%23U%#I6YPF1QB2-DN8=))ZBZ3/
M1E=0^9ES.IO>][Z8IRR]8W=D"](Z(??7?[5L8Q9.=2W:-3IU%<M;JY:W:=*J
M1*?CWEK=04"$ JZL_6?3Z66;E[EK=7+6ZN6MU%)4I%ZRQ^R^D=,G45RUNKEK
M=4PQQ$9LV/[.HC[YTE/!ZE@J2>HJZ=,G_B;]I)/4729Z,-,"24\NBE\=NFO%
M;$_(K-;:&V2<2QJ>L@@B +IE>#W7&'OKO]JV,+LG!,/LNE#]=Z]6?K/ *E.D
MRW^21VOR2.U^21VDCJUKQUEC]E])KDW-]?DD=K\DCM2_*\(AK8^.RE^>>DME
M/2QVI)ZBA^,S9KCFNGW*/YO'ZDGJ+I,]&&EA.+?&E2PO/3AEEBC*6TFC8K)'
M! OM[^[_ &K5$D.<%C8@):F[V72A^N]>K/UGL=)GK.LL?LO8QWC219'=HW'V
MV*L=23U%TD>G>HG&'X@_Q"5.<+D45DK9,&"2>HNDST974)A=;(3A!$6*D:U8
MWJ,/]1;@!;[\[_:M<.,G,)+[/I0_7>O5GZSP_&VF79%_F_$M?S?B6OYOQ+4-
MQ3"H$NK+'[+Z=\;Q+(-?S?B6EO35B\Y&M1J&Y9TJRFSA%-))ZBZ2/3LJC39,
M&"7Q5SA<BZ=LG_B#_)/4729Z,TE&+8#,1_S?B6LE=,K,E8ZP+*3I7C7WUW^U
M:XI9.41/V?2A^N]>K/UGT\_N'9RQ^R^D'7J3BGX]D/ \K_$\DZ23U%TD>G:Z
M@\8?FL=H0A#%TF>C#;&"*/S_ )F3']/N4ET\:*DTB;HHPF#\0SI81G)L:^^N
M_P!JTCS28^O9199)?L^E#]=Z]6?K-B?7:,NO_N^6J_\ =\M5_P"[Y:KISR--
M9G**RQ^R^D'7J7BG/\?6O<-\;2D,SA%23U%TD>G=.HC%]XB_UTF>C*ZBL8JX
MU(T#@O:E9><\L% D<UEDN%$XJ\31]BL=11*.^^N_VK3"+)XR[V?\D2*L.8[6
MXSC.N9<)NF3GW^2)%7\D2*OY(D5?R1(JPUA-TQB^U,>F5]DTJPIB1QQ9JX(4
MSF@%TD/_ 'L-X[?,:,].G2I(%[GAC%Z_&#9I)XVV2YAOTD2#MPUC5=C%BI:B
M1N225=*D:<U/\D2*FGI''XT+Q_%H @]^=_M6D#9.01;Y*=_M50-DY_*?DMW^
MU5A%D\%#[@HM)I%D>!/;\1,L63,DQGQB]KWAXGLQDGY.]/7%P-E32!TC*:72
M!PQ'!YLYE17$#^_NK[DJ5R*\A22E*HB#$USB?(++)NWX]8@KG5JR X.\>A.5
M7)>U1)U8Y&\,^/FZ62A%')(O*EC$@FV0TL$_,"F^4SF1VE<V=C 02#JE*Z)9
M0D+HC?8>7)DT@^ ._P!J*+,.,CS26Q,GN HNVRW*\:A;!$ZQ+$H[(66 N"6+
MVBT/GCJPQ=S/*@B+'25ZQPHD2)]PY)FU80?&%".-3F)QN>/J*"%K1-D-R"VP
MYA,?7^1XSC;EB@EDR"6D?<<3O(+-+HW9,:CB.%/1T<0W=)?"IV@A#0BGS\.%
M,$"G:V*-CT8LQ+$<HQ1GC4SE::RMC R&Y&^ ._VK%+)S>6>XV++L.@%EE6X<
MBK6L&W@$]H0! 'AD]K>"3>KD$7N$(06\(JPSD:10*X0B#PB2@@  )2%"09_V
M@%@+L$LL(CD:13<198PVM:UN'(KA$E#)),+(3)DMO@#O]JPXR<OC7R8L(XI(
MB2$MZ/\ Q[?_V@ ( 0(  04"_P :]K7%04:@5!;KT%"G#5TB>]'(.SXN!M7F
M@NV.-JX%;:N&45W!V]F GO4!(10"$@:MW+;2\GXLC7JD V^2I5-6%85M+VM>
MKDE7JZ1**KMZ 57:VV]79FN]<B::_'F>KQMI[+QAKO5XJVWJ\305>)):5154
M5801EB;&=6Y6_%EMJ_&7.U?CCQ:AQ]YN&\:=;5>/.]J4(%*3XJB=5J&D4C2J
M*": 7L1_Z#LOS4%:1&% #&[41EK4N>2$E+'Y6HH0A"O\62N2M'2.2E"HE:4:
M&P@WVC;[;3;A9!7;2YQ2H@KI I4U_P!^-E'G$"32)0725]2'T \ J[;7TO?L
ML89_O:;+\3(SCRDY;C)A#H8QF"^/DK%2>D\E5ET1*$8JYLB/JYMA7V715P:!
ML=4[4B5KE*XSY%37O91LRQ5_];)1 SJX!17 **X!17 **X!10D9P T4F,.MP
M"BN 45P"BN 44:F,)M049PP\ HK@%%< HJZ%1:A!$&^ED)][&IS"=BR$^]C2
M1DWT+3'&5P"BA(E :O:]O?TWF-C_ )3@JXQ;LMO_ '94;BF[=;#CNJ3[C8.)
M <$P%RQT#Z#"[&@& 18] ?0X[VD2:PK:J$X3PWM<-_?4WF-A_5\*V[?;>NV^
MCA>_C=MZ[;Z-VZ6>6[;UVWKMO7;?1/N'&NV]=MZ+/,*N 7?"XA[!T#Z*6D>(
M#0'T..]H(;!"N4"!?MO1"@9(J7A[I_OJ;S&Q*57BK/9..^U;MTLMVI^X.NX.
MNX.KA%;1/N'&U[UW!UW!T6G-,$$-@!<1=HZ!]!A_A'4L(\(= ^AQWM!%885J
M<0[]P=7M>WP!-YC4TP))1YPE!WLG'?:MVZV''=4GW&P<> @(QW,%0/H<?K1'
M^( PL)H# 7+&#Z''>TC56!K>UKTI16[/?DWF-9.J\%#[-QWVK=NE(Q%D\<HK
MCE%<<HHQ0:=:D^X6GF$UQRBK+C^VU^VS@7V&: ^AQ^LL=RQEF!- M(\0 /H<
M=[H!0<77'**(7BN*E9?AG^^IO,:R)7Q+C[-QWVK=NEOEME/N'+5"9WR59?B$
M: ^AQ^ND9_A#T<=[7!I;TL3V*%0 7,'3A?M/]]3>8T6J;)$@A7%?V;COM6[=
M" $8>$3UPB>N$3TM(**+I/N'+5"9W#J/+\(V@?0X_7HB/\0%..]I$?88+VL*
MW")Z 4671A@2@F#N8/WU-YC25J^Z5[/F(*4G6/'JF5!(#S$%<Q!7,05S$%*5
M03PT6O" M4HLHUM>X;\Q!2DX)XJ"X M94?8^^@!B+'S$%*3['BJU[VN6X#M;
MF(*$XT:<8=?WY-YC1X5\8X?)2;S%/"O@V_Y+3>8J5J^\;\EIO,"%8-EJFZM7
M\EIO,2)7PS=\F)O,2=5XR[Y,+'X9AI@CC?\ 'M__V@ ( 0,  04"_P :XA!#
M8;@D!0W@-#<U0JLO5VI.ZVO?_OQ8QX:R3+/31>UG-MO7&)*L:7?V9BFP*,<%
M5&*G ="\05]EJ4WO\6<6I"Z%NL-7(Z$$0;Z6O<-[*#PT%>N#079T#5GQX#5I
M"]VM^3OUJ_+9!09B_=MIJ]VN&<O%J#/'2@SU;2&<H3Q &6<!YD+>SB_-VZ]?
MF;+>]I?'A7+ED=",,R8KT&6L J2.B)=\5<6)N<Z<H>N24,@P%_8%V[1[,6?1
MMJJ:I3"7?4!(A4V1Y4X4WQ9"DH(0@#\67,Z!PIPAAX*4-QZ<5P"#M)P[;]?C
MHG5K=M-C.M<AMD31(ZM:UK?&CTR=4%;$4AU+HNO348E,!5[7MH$-Q7))[ [3
MU;@H@F3'JS6B%@!1999(/CZEO1*Z50U =2J$.(*LPN*6@D7+#LLB'F+H\L:I
M]<F]L1-A7R*MM:Z39@:'L#LGJ2DU<T25S1)7-$E<T25S1)0'%,8.CUA*<7-$
ME<T25S1)7-$E$+"5 J&XIBQ\T25S1)7-$E6<TE[A&$=M+N:6UR%9*F^MW-+:
MY"@M0'0U8F)KFB2@N205[7L*WORSRFQ:U[W:45FYNV7CZ=E)YJG??;#1OJ5^
M:V$ZDQ,,HP)Q=&;PDT1!A1@3B]#-XT;FG):(%]4BP:8816$'WU9Y38BJ'CGC
M:[+7KNAKNAT:;6NG[H:[H='??-WG.Z&NZ&NZ&NRUM%?FF>UKUW0UW0T<F)/"
M8"Y8V<=[ET9O*;57@F:&;QHW/_*&*XQMB0!ENZ&E*,I0"FL=Q)??5GE-B#H?
M ;_9-'EM7??-][66>(77B%UXA=6&$6BOS30((:\0NO$+HY602$8[F#9P7L71
MF\)2^.FIN5>.71F\:-S0P7+&V+ %6\4NK""+X L\IJ02-0<E3@2)O9-'EM7?
M?;#1OJ5^:V$R4Q2,LL)0*,WC/NW)+X)A)HB#"C0G%F;QHW-.**YE]+7N&Z-R
M%V^_+/*:PI#Q+I[-H\MJ[[Y&6 Y3RQ'7+$=<L1T2D(3BI7YIM3$J*Y8CJ[8E
M[+VN&[2;WBM#-XS[LTH)Q9Q0B#&U5X)AF\:-SH:E3G5RQ'2EK!8%-YMS4OOJ
MSRFL10<&S^S:/+:N^^;O.;*OS3-JYE>&I;S?"4Z&;QGW=.*7QR]&C<U=Q6VN
MW*Q* 4:8$HNFFU[)O?5GE-&U&)P7A"$ ?9M'EM7??%F#*%QZRN/65QZRFU2>
M<;2OS3-JZ%>(GI,;XQ%&;QGW>CDE\$RFC<TY);E&!$(-^/5T8>:=1)0SS"B[
M$E^^K/*:01#WS_9\G,I$FNE*U6H1*A\G,KDYE<G,KDYE(D(DHZ.:QFFH48DF
MH@V$'DYE(DPTH*$TF"$B2B2AT-+"<7R<RD2:Z4%7M85C6DH5^3F4!G_V0G*3
MA]^6>4TCZ#ES3\E+/*5'T',7;Y+6>4J"(>X1\EK/*!"(8FU&%O0?):SRD10<
M8\?)BSRD*0\,U_)AQ?BDD$@3D_X]O__:  @! @(&/P+^FO!JLAA7;=D5=:W5
MM2<GI<3)4I[F&^*]"\"=\#NI5R9OPGJ7AOR%5@^3WF#"5VI@Q054#C79A"Z[
MYN/TMM\LZ'2+QPA"7S7RIWZ<M['E4193 V*MK<B[4N7\(5<F5\#>I>!*^$+P
M&+P1E/6O"_4_]RW'?$5^/XE;-&,?M79?-_3^U=F:_,MKEGB9[-T]6<+8>"'A
M&;+.Q*%\]/L54]L<:[,YD<+NI536'WG?M6R7,<.+[ENM/O!>'^IG6O\ ( 'O
M-.@^E82G1E_E-GW8ELSOES/;9EZX*KRYYB4/\M@^(='4NY&_+<8XZP=6*YA,
M=V_RBW[LRA*[#,IR]2VG5N]+_*=V.@V?; MGF.P[*%M,(+;N%WS'*M\,[6D$
M9J8\PZOHOG%]@BSE_EROU9;V+*HFWTWM27%I4)XVATBH]6A0VH.Z#5<1/D)_
M,-W&[6IH7>SG!LL7RN[_ (\0;^8VXA>QYEMS"2\]/J!\E[AHR6+YK6O&3[9%
M\T.8<NCJ78FLRPTKLV74R?\ CA5A-03BP;?/3#B %D<Y@,R[SF71.88!ZC,A
M^<:;J7R3>(Z!KNNQ>5Y7E>5Y7D7&$!1%EBO*\KRO*+[* X0@5>5Y7E8H.J-,
M:E%]EQ&I;+[:8M%2O*,(J!M\_9QC3<Q-BF<Q><ZK!8,UT[%=.X:#Q7(XJ&\-
MSLNM18ZT4# BQUB+'6BD8$.&CO9EEZX_WJ!M\^9QC3<OAXC^R,=N:/DQPZS<
M'B3L6FZ;PIF/53%I0<+X37=(H&"CO&[XI&!#AH#18%W3*J+>Q1A'GS.,:;EO
M+-W98SG[H>3'#K-P>).A[-*L*L*L*K%#>%,A[=2L*L*@!4@T6!-9T"@8$UKM
MPBC:;N&@8$.&@.%A7>,K*L*K] ,XQIN'37[C1$XDZ>_>>XG+Y,<.LW!XKD<5
M#>&YBZWH1>ZTT# FX%L.WPBQUB+'6A# APT=U,W;U,#8MN3;T>?LXQIN.X&_
M-.85G5Y0<.LW!XD7MWOO5N96YE;F4'V4-X4WN[\=2MS*LU*(L0F=-(P)N!![
M;0@]MBVV[X0P(<-/8-2MS+9FV4&%AK\^9QC3<.:/#E]GKSU8O*#AUFX/$G8M
M-TWA3,>JG9OM1Z172,";@HV';AI'#1NYR@6#Y9H#&VFCW?/F<8TTOYD_A;GO
M9UM.WCY0<.LW!XELNW5NK=6Z@6"!C0WA3,>JG9O.H+*!@3<%/=NWQ0.&CNSO
MA0-BW5V!!;;K$7FT^?,XQII9R;;7':. 69]'E-TK;%55P6D1K6Z5NE;I6Z4&
M@0KH#(&H(0$(4Q%JW2@YH@:(;)0($(4A[;0MTH. A51$6J#Q%;I79:HO\_9Q
MC33,FC<C 8!UV^I;.,::)DT;\(#">JWU,9QC30SDVV-&T<)LS:?4QG&-*VG;
MH3^9/XG9KV;U,9QC2G-'B3.SUYJL?J:SC&E=P-R4,YK.KU-:_H(*=-?ON,3C
M_I[_ /_:  @! P(&/P+^FO%Q "WHGV+Y;,JJ(;@'6M\K9Y@0]JB+/2QE3I\M
MDUMH<8'.H_W7+_\ T;UJ(YB1#C;UKQ9?Q!0#A'#Y.IDQV!I4&27#""J]H8!!
M1=&-U_;.Q=7I;N^<8#T'\0P'[#I1F\E\_E_UC%?Q9 H.MIB+5%KW@X2NS.FC
MWG=:[/,\P/\ V.ZU <U/^-RA_<S<J_\ T.R-ZEX_Z)?[5XC?@;U*V4?=^]5M
MD'W7?O7:E2,COWE=J1*RG[UL<[+=)/3O-QU C(4)DLATMPJ(K!0DS6F9/(CL
MB%0]J[7*NA[J[?+3(<+.M5R)H]QFIZVVMF-=P]15;WCW"O&,>"9J:O\ %<YW
MN/&EH]*QGLA._,VIWWXT7\O\V3[+?AZHJ!'EQRD\_P"!,,.$G\7[LMY?W+O"
MG,$/= :1H..XZ%&4SY?YG5-^_%%;4_YLS(W)UY%LL #?2_SV?,_,*C]^.*+^
M3/>,Z+'=1^U2V)C2UWM5=T77?*\Z^N:TMKQ%KLI -.SRC(B^X[HQZA6A,YKY
MT_\ 2,5_'D4!9Z;V.88US?:MKE7;!Z#6.O2H[&TSI;7]]%=$ H7?*\H_Q'EE
M6(O.2Q"1RS7/FF\$)W\J=IWY!9[QOXLI0ER@&RQ>%0]0/\F6UQSY;5&0YTL_
M$-1SJ,@LF## YZLZ^9(F881T11VA PNI/*GPRZ+N$5GJ36S#W7\9);C<36=D
M9!$]%]=SR; T7S?.$_;V>HTV/_;=HNIO\BZ_V&Z7?].0W0[V^K^17\BOY%?R
M*_D08V.T?91LS(Q*OY%?R*_D5_(MF7&(H+'1VA[%?R*_D5_(H1(Q+:88MI@8
MQP(B7:+B!C' MJ78*8/=VE?R*&U#"HML\_F_3=HN8"U2N4_$UM?$:W9[IF/5
M=,XA0WAUW+N'70_B-SM,LZ.E"8S=-#L)0F,M"$QFZ:782G<6JC^WE6WSJN/_
M !7PMIMA\^F_3=HN9>UX4KMG%9^J%W6K%908_GU!64MX=:9CT%6*Q6*JA_$5
M,C_MUJQ6+9>$99M!3V7@=/\ I0[":.Z?X;LQI=A*=Q:J"\VDHSY@C74K K )
MEXT0/X3#7K\^F_3=HN7<Z[?G.JX6U:8YO)GCU"X;PZTPFRO05O#*MX95O#*N
MR0:'\14S:,+-:WAE6\,JVG.$>A%YM)3IG2='^M#L)3GL\1IS4=V_Q6YQ0["4
M[BU4%AM!1DS:A&HK>&5=D^@)OTW:+AG+RO$>X 834F<K+W);0W)Y,\>H7#>'
M7<NX==#^(W,&;M\H2V;HH=A*?A7>L\-VE"8RT(3&6%.PE.XM5'?R=^^*8MJ*
M[KF+.GK\_F_3=HN#S3O#D-C[SJAK.+RAX]0N&\.M-EOW3'0MW.5NYRMW.5M2
MA70_B*?WHC"&M;N<JH5X2MDVA&5?:=-+L)3\*,M]A1EOM"[I_ANTIV$IW%JI
MC,:(K=SE%\B.T+U )WA5Y]-^F[1<->[Q9W;.#\.:O'Y0\>H7#>'6F8]!NG\1
M4SW==.T-UU?6A^4U4NPE/PT=XSQ6YQ2[BU40+J\ ZD6S3&:-%!F.L%&%QU>?
M3?INT4RN3;^-\,5\XA$H,94T#RAX]0N&\.M;;*G!;^A;^A;^A%LUT1LT/XBI
MGNZZ=L;S:&S+\*'82GX:>]9X;LQH=Q:J.^;X;LQ6TVIRWROF.)0ELM0EML'G
MTWZ;M%,W^1=8P;#<)K.0?\O*;X1EN,>U&X#VD" 6^%OA;X6^$7N(,10Z8'"L
MIVT8[4-=):;"M\(L<01&@NVA646N,8FDRW[I6^$6.,8FC9=8HRCLYUOA=M]7
ML"V90\_F_3=HIE2#XA&T["ZO-9B]2YOTW:*)4@^&#M.P-KSV8_4R;]-VBB;_
M "+K7G8;@%9RG_CZF3?INT(,96XE2N3;^!D,=\XS$^IDWZ;M":]WA2>V</X<
M]>+U-F_3=H1YIWB3W1]UM0UG'ZFNE?F:1E3.7E>&QH P"K^GO__:  @! 0$&
M/P+_ ":ZR;G<(5NCI6LB?*8B,I3EJ[(-L$I[.#$MRMW5\>2/9(TBY:_Y$MIM
M+;^^^F##;>T9;_\ [<F]SF8FGPG!@#-U_*!PO9+A;;"TJ_F[3:XY+IYA5ZZ>
MDGD]D5'][+'%;WC.>S2H3(]NG-$B5ZNB5#=TH5<]-%_@PQ:_M A,6\G2%IO<
M%M%Q(2&2T%;E!,G7(P=+K9$*+R@(U5&WV'&WF'FP=9>:,7&G6G!0VW&W 50-
MLP6J*F2I^%G8LR]0(<E@U!UB4\D9T23\1[02BO,29+S8U)N:PT_&NT%M?]$W
MQ+"$-^LI"N:*ET@JBITHJ/YX2ESMZUY*38V?L>4P@C(8(ER1$=!55>A$0L_N
M:A'VA]H6X7>LB#8]F7AUK4GOI$QF$SHKSBI>"N"9L?V/7RVE[AV_6N_S'"%?
M%<['%@6WA?UKB8<9DO[FM(9HL6T6.19C:U9Y2(T-NXIETNJN#?N87B9*S1QZ
M<,V0_5%74AN2$)S)>GOI/V>75]7!CQW;CMQQPJD#0'JGVM%7-1'B<=I/<HCG
M-I3\+=GN\,'E%%1F2'DYD:O.Q('KCGGI6H+SHN')5GUWRW#4M+0?XFP->0XH
MU[5I3W3557ET"F%%442%5$A)*$))DHDBYHJ+W4("("3D(5423FR5,^3&IN;+
M N2H2'A6G15#PO#N]T;KRZ+A+"OLZ74KA4;W%?6T7ET7>>-?9TR$Q1-RWM>?
MKW*4XO\ I..$6$%-Q7*B>^=0U]LC%27")^L$G)*9LPB7+I(HRJJX3_'*TYEM
MEHS\"T@(N>-2W"*2#5=)6Z'1:=.EH2_AQ53MKB>]*#E_Y'0+^''6C6-WP'#E
MHB>'R=P;7"\6V6,^2FAJ>W3IKJN#M?X,>5LML-:^X=E-I3HH1NYX%B\07[.1
M*B))!SMT1%Z75%IF0TGL ?A7 .M&S+B26T(#!0>8?:-,E14U X!)AN!.L\>Y
M2Y "\L%J'#(&V=?4<DD\.@=1!U4H2Y5RR7 A)^SZ"ZWJ0J.6ZRO:>;4(''TZ
MD%5Z,!VO[-+8Z(ZJ*>V-L/D%>70+FE.LJ)7-,5<^SB"S0:5':U@9#)?>1)69
M9\M,,WJU;62T72)K6-,BVI&":XK!Q74:&-*)L>)'<(2ZN:$N%U39C7@.WR5K
M['#%Q,:CO1,^!RVW7]^H0C'^'"C8[@5QTU1PV8-Q1IE4JNE]]R(#+!+3)#5%
M7F_"IN38?9IZIE<X.F/,KS*ZNE6I2?THEX*8<D1&DW!;@JO&MX%VT Z7[=UW
M?ZI74Z:85*Z21:**Y*BIDJ*BYHJ+]Q/PT'_25!_\>^9M<UY2LEQ>%HQ->K D
MNJ@MRVZ^(VI+1WFT];E3"W$ZE&N\1AR.7N0.&RU$?CIX0T"XO]+WGOE\')^_
M@5M4+L\%2H5TEUCP1SHNEXA)R20KRHR)JG/@)5_<=W+.'/3)U,VQM?Q8:&1/
MT_UID*^]3#<>(PS&CM#I:8CM RRV*>Y;:;00 ?83\+D=RMXM3E1=-T@*D2X(
MO2;H"H2=/,CPN"F')&WWV]Q0AJ21UT0[JV'+3A.'V:5I'G T,N8,'"N461 F
M-+1V-,9<C/MK^,TZ(&F.J2=\VUX=9?YA[_:]Y=77*CG!%QXLS-58?@RJJO.[
M(9$E]CN\&T0B<:$D%Z8[Y&!&Y/STA45%)$6N@=3E.0<-2[S2_7$>MH>"EK9+
M\2&5>TZ>EVJ+RZ$P( *" H@B(H@B(BE$$43)$1/PWV6]VN'<F<]':61-QFO*
M4=_)^,:^^ A7!O[6O$BUGRI N.J?"YZ W)11FQQ\)<=<$4^R/3(@57M]HK<H
MVD?&,T9'M4<$Z76PQ15TDBT5%R5%3E14YE3&2U[BF7(G\/@3PXU+RD:?Y\D]
MKO\ ;%K=ZLF6=O-6EJAAK9D7%^J*O_I.."*^%<-PK=%?F2G?$98!7#\)+3(
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M4[8ZJ1F31R2"T$@WV18YR!2_DV XDY[#=%?>0H]GU%(0:Y#*I:"!,$%.0
M H'X XYR4T&E]0O($KH, ( PJ*=TMP!M358X4 ?,1"0.A&XUDSSRY/LKGP8L
M?0W-QP@ET2<KUA&]OZ'I[N98UNW 22!B\F3)DR<\::)'R1$O%1T/.)L-ZS.)
MQR9"HRQY85UWKF!A8S*P$KB'*(5B[]H,E=1SBPI:07P>>X7?03@4BE[S1]IQ
M G;!Q*/5H"HJ&2!%KE/S$TT3((BD)%$:%]04EH$B )Q1J1F#YTF0#(E(7O=#
M"'O]$<Y<PY&B<PY<BACNVD ""9>?FE_M^GKU0^QTE,!.]8B!@UU]K[((0ZP!
MJ"8Y"@')TFIHQ0ABP,E&WV(1L@X2:M(F$I=LJ2& F*3HJ%XE'N+QH@!,' ;T
M8>^3,X6A&$;CP!U)B](^R8@T2A)\NA>W*E$'Z'N6FZ^%:LM*U7GPW]#T]UNQ
M4A?Q<$)++R08,%NV'][J[> LC#BHZUP/6@SJ(EX02NI@36%F"MDAKU[/\.UY
MN5KK21U-6)A !C-Y"@&4NV5(3 3!(Q%(MON0C9)QDU:Q$,G2:FK-*&;!V4Y"
MCVYVDIFVOFA&(MP@AG?RM+/HAC#A,-<V&4I?TQDK/T(YO])D!/E!F>9?VUZ>
MRJ&QV#1Y!#,LL]B%I()Q* J*1)H*G*4 VQJ;63 D+,F$F12 /F(E)72K=>#T
MQ03H0!!081&*' 0H?_.$%N4%W<ML'NJS-6G M^\^DS4BY1%>:K7F[ $EJ-DT
MXD[4/H,G,;AO!10DDV'G46>_0"7D0&Q_1]/=>.9)?1_8$R&'D*E2HQLE=PET
MY-">90V.Z+7V\DT]3^0)+K&*"1,*5Y<+)+,P*L+AR<Q0"Z8HEDI# L 89XO7
MLFQ*<^+^*XEHB[+F1288)%,* "<AA*W:WQ1JVR+R:.8*VA H[<@"V$&4NNH.
MCI^1.QX4(S&"Q;Z"YN@S'!%A,[I$_E2*Z+HJ^*4TP&CR#&T)B41%H-YY21(D
M2+&T)B43-H%YX+;A!;@,M6QK[I@HJ^#I3B<0VKB1(XN'F%7OKT2^LL<V+31G
M=&",")QX26_#;27] &!"EI*1)7X (5TB6CB5F-9!('I@A I$D2F N%6Q!C$(
M-6D#Z%Q*)FTBT< @Y;-0!GDE02-:6)N!,,B((.!)+XMHV]TLO=(TIJ?81T'R
M;"9C,^@N</V%(L/B 48X_P"-<X?L*38?, HPQ_QSFR#$<16$QLD3^B2J%;F7
MMV>'< LY+4:B"3A^#5)2*L2%+K.\8N=1X&#&<.%U:&BF@_\ 8@'""FAB6IY:
M&WQ!"Q0II"'KHL4@1D@0LT:(#\'.V.'ZHTS1\:,"3,\E:4T<IGN4K#HIPU L
M2)?NN\5G-@HH@FVD(DG"EG'W*REP-*FL$(1H3 $!P+ 8U$9L>)S03#!/=FF7
M%Y^;,0$"- !,N@$HD7,Z@0C;#,I/JD9.!'#7W9\%1,*^BD)SM7N4VD,*;)C4
M1[I4,\:@!03!_$PT0';D\!5(*>ON42*V[:8+K#E?&ANT*<1;5 J*T,6@.&-M
MY31X3D!0+<22P+^.#/3=?0KD6>_2"7F0&[4[@M!!0DL6'E_1M?GHL8R7 @S%
MZ.<"8B *)B^-E0>**PMXK)$HMZ1H1YA^@(E5:2OG!YVD3" "&&E0GZJ )05E
MLFP4;C9U-E77VU@6KZJ@/Q?UCN!#8/6BM;P%_-68,:#-PEKHN10F:@[>!>L,
M;RI<+TP*D)P#293M291J.X D-R ,PK9JD3 .X04AJD?JBK0"SA1^M0!7UD55
MW:!:P^OP"&& [!E3!((ZQH(V1PY\#N7/9LOA7!LTTA[F&!2 "(UI3<I&\XAE
M<$6FC+?VCD)R)5DFAD9H\+UNV/;2Y>B@< (#>C=F>3R-S8+90(/@<OPP-2_F
M.(^A.;_28%3Y1(GF?])#NC0HCA6XN7!XZ)&H1( L%6;0+:4@VH$6;M'Q$''8
M0 "I7)@G:Q; 2,X5-G*Y@5#!*GO0!NT1P:HXTG!ID4H&ONO)(LB*$0$, D@V
M8@;S<K/J.9,L(%VAG"D!:"YDL:T/TP (A"\7V<:>$+<X!*.$X '2!%)@($E6
MG0:(<*0HAXWO2 0%"(DB-D1LB5<[#=.B8(EBKN*+ZLV2[K4UZ2:I%?X)M1Z%
M##@B#A#"@3"  ! !8 KI#?E6\WX3E;<QO@%<D6(BK)1V?Q8P9_0G)3=? %66
MA:KQY;_&(*(Q0LY%@O1)-9\PY6B<@Y<W_P ]_P#_V@ ( 0(# 3\A_P#-=Z!7
M:]:3>'_?:LO>'W8^*PPO=_$4'"?$GWIQ).['PTB,./U8@#R##UEZ8E)0S;)\
M450!K(X]%M2:1G9_C7&'9^TUBW]P]Y:NWE2^\5$B#9',9&<Q]C]O3ZM/2'<]
MH\XF258!J+=V^"S=4T17$& :!PXW'XK&EW7[5>']Z"LOC/X*0EE[1\4HS6EJ
MR8L=.M 0!=OR&B+=M]]4S!]U?93&Q-Q_8IJ;,QZ-U?HIVIX1(1W*&BJ+U] ,
M8S;'=K$5E%[)_=2/HO<5+L<O^A6%=I]Q*RVFOYC6-/I*\"KXP^JJB^Z^.?D*
MCKSE\&&@F54S_ I.:&A*(R,7J_.V#6%LS<-\R7D,'NU)A\WJU:*/K7NL/ =Z
M1JIBK+Z_5VH?RO1EZ*@1=3I3R)O0)*S&3VK!7FP_/GP,# R/@TAP05"Z(L;]
MK[F-U8T/3%W_  .ZE5B+ZWVE*X]S!\U&CZ@,5(X'O+WL^%H69HP' \HJ6;KS
MXU"$Y,/J 4[4TQ2)!_UT"[E4MM*N[WND[*E;$NJ5\O\ @,)W2?DGV58]H2_N
M>RK?O0A\FC[0,GI!H,H997YH98$>L66>Q5Q)<8627%9U ;M)M<HPV, ^7-?\
M-,:/PN:5"QZ[/H_,YFTCW5L>JMCU5L>JMCU5L>JCCA3CP;QP8QK8]5;'JK8]
M5;'JHO')C'@<<*<:V/56QZJV/50$P>R5 MW>(0$$UHL$EI?D" @FM$X9$\0Y
M>]L>_P!JV/50'LDI&!!_?Z;HY5!@"F9QGA^R.;V?W<WO7QPZ+8Y>BV>'M7QR
MPIV.9UI6+A</:OBL:I[;UCH7'VKXKHMWA#*<C[OVY-.'!^SM\4XMAA_O=-T<
MMR8_+'CUHYQ3"M]K?>!(G+1OM;SPZ+8IHATA6^UOM;[2F+P]J^*:65;[6^U-
M=VR:#!0/K1@XH>G[X>U?'"V%GU/^8^O'VKXKHMV@EBL)(B@BX)4Q[5OM#63*
MYUGP&4RG[?;^]TW1RRBS_C7T]Q_C]EY#HMBD$)?P5^N:_7-?KFKBP=N'M7Q5
MG5V4_7-?KFI]3,I 5A% >E&!BCZ_KA[5\47V4F;<+9?;=/Q_SA[5\5T6[0PS
M6$431XX"$S[FM?KFL'I] Z;HY%CA?8$M8UL?*8\8'\?LO(=%L<O1;/#VKXY9
M@;<S_P WK&HN'M7Q7O'S5VK/J?\ ,&L8)[;UBX%>U?%=%N\")HS--G;B#".Z
MI8H&.KM^/3^_TW1R1[X'K,X=E_D]EY#HMBK+HCX%;/T?BMGZ/Q6S]'XHB\AG
M .'M7Q5P(Q+#A_U6S]'XH(09:% 6,)J*,#[G_(X^U?%>\?-8N!6,$]MJLU9]
M3_F)7M7Q71;O$F%-&)Z-;/T?B@L<V)+1WVX$#1//_9_O=-T<DFY&/<O\W@_D
M]EY#HMBN@V<WM7QR%<6-'C+\>*B!I/'_ ">/M7Q7O'SPOA]MU_/_ #CT6[1C
M?"@$ECT8U%F#=OYX8T!18B@ ,@>Z_?\ O=-T<<[63? /*#S2=I15U7'^3V7D
M.BV*9'*RK;^K^:V_J_FMOZOYJ8.;]'A[5\<A7AA1YR_'GAH,-NS<]N'M7Q7O
M'SQNQ;]3_F?#HMW@;>SZG_,*CF+R:5O'W_-83]-:2K9[[5B)G][INCC,[[9!
MYD_R?WA1L4$?=?OR.R3+VK]X5^\*_>%?O"G9(E[<&TR!E5VUW'>/QQ,X1FM;
MU"GJ 0_;@+PAJ4O:#/CCH5?N"F9 A[\ 3P*ARWX/X^*_>%6<_=_'YJ0\Z&1V
M_O\ 3='&34GV:)W3Y?XOINCA)J'[-$[)\/\ &=-T<)G?;(/$G_&>FZ*3M *N
M@8UG:R;8!X >/H9])Z;HJ3<+'LW^;P?XWINBH]\#UF4.X_XVTLVSLS2QRON*
M7_SW_]H " $# P$_(?\ S7[J08KXW%]\/>L(SNH]B?FL/CHS4_(G<'Y*-&V<
M/)EW/2A!B+ZLZX(@+Q!C1P<FHL@W'V0T)(*L/ATN])2*V?QVU+H2Q7N6'V ^
M:LB/3[ GWH7#W3S3"X$_?]QY^K2\H6;=EN:Q=9&IDH7@+&Y]][C%2HD#>>,\
MTU%-]B"^]9CVA4L9&PU*L.Z?*U#D&\O=)H)!&40]95@94G#\ J8(-'\0TG/=
MOL"@8WL- 2\=A^]"+%E?:?LAJ<G1 !S$LE6GICB++;$PP7;9$-3@N6^@[U!]
MD_-=$"W/BHX7@^G-RKW5/LC66VB][M83.L([I#:6^7U4],G_ &,O$[16#*S-
MIOBH1*DI$Q_@B#SZ<RV4:'"V!H3;9JI?HHO(? <<C1O92P[K!]@5'G88@\<?
M)-E'B/ " [!]7+4^BS]@5$AT"/@1:/07$"/HT]9S>BQSX-FN9^21VX+V5)@+
M%AW?=<A@-86_4]+YICC"@ 0/K?;(28[.)XBI1'6#@I/MAL?:SR%+PC:L$< >
M/5A8!SX3&-1/JA%NU@40&7OL&:V,VA\V9[>S?LB;%&7F  #8+?X /NY(]&/=
M4UHZQT&ZD79WV4:5O($/K%[T<-*LD<T<)Z(^(0W2HY) XQ>2!&F*@PGD: ^K
MW>V!D#_#0$'\GFA?=>(CUF$[',8I1.()PK>JWJMZK>JWJG"FP=W L\";$UO5
M;U6]5O5-G@3<C@X4V'LK>JWJMZJ;.\7VFHN$S&>+-HF*-"Z21R,VB8HVGDBY
M'%V!L+OMAYK>JO(6Q/?\T<87F7/[_2M?*"-6P!G1GP??</6QMS>]YCJVO#K=
MW+UNSAU;7EFGNR=,G*L.(Z/&'#K6M8]1ZF9YI8I#H[G'K6M=;LX2AB-K$G)]
M_P!\A:ZI_P"AO\YT&:2D[/\ >Z5KY;:3V/#'RK,R>=P :VGI6T].#V!OIVGI
M4%P)[<.MW4!)PI;3TK:>E;3THP@.'5M:M -.T]*VGI2D,Y(7.ST5B&H]&*0.
M"?=P=:UX7RO=&S@^./6M:ZW92PEPK%1SZT5($ X;L9Z%?K*8E@L%YWU*PLT3
MS'X?WCI6OEA?A_+'KYX7\?N?(];NID0HOUJOUJOUJFH0V1X=6UJV"6=BOZU7
MZU2M#($5ZUPK&/SZLTKL"#U<'6M:;8SUA<[YGIGPNA8_ _9]<^'6M:ZW9220
MX5C'H]*2J228;CIKZU^E5A ]F?H'2M?('$F6X#W:P9:=A$N[B[_Q^Y\CUN[E
MZW9PZMKRP:@]@_[H474!'6[PZUK7LOQ5D+WIF/.)YK%JO4S/-865T>*ZUK76
M[.$>IAW(S-]L\M\+./">2.99HQ678SGW&_K_ '^E:^2,<^\ ^GF'\GN?(];N
MHPYO,L$_)6XZ-ZW'1O6XZ-Z<(&1BOSPZMK5U6#NF-V':MQT;T]CD;. ^M.;+
M0]RIWS!V_P"I]>/6M:]E^*PLKI\5BU7J9/FKH7O3(^<'Q76M:ZW9Q5DM>#ZD
M/K6XZ-Z>L!,KSVSGUX75;OQA[1_>Z5KY(KPOF6':)Y/Y/<^1ZW=S[=6UY%GL
M)]6'Y>:E[J_.'O''K6M>R_'"VEC\A]STSX8W:ZW93,6QI)8JT@!;$^$8/VX8
M*-/_ #S2RS2E<%'H/D_O=*U\<0 EMC\3X*-@& ,@L'@_D]SY'K=U 7R3W(^*
MWGI^%;ST_"MYZ?A3J#EEJ:'#JVO(NJC/AL_9\<-?5W<L^_#K6M>R_'&R%[_A
MYQ//#K=G!Z=Z7W/7$]*!JAF6:!(]H_%95.N'IA0@R_;=VK#NX_+Y;_WNE:^,
M*?O#3>$[?R/TK00$JSL'VY#XD-YU6OTK7Z5K]*U^E:/B0VG4>!T8[@YU8+I-
MO^N-Q,D>S3D0]FDCN1&6OVX&2-'!SHW"DMQ&*0Z>Y7Z%H^"EMV#@] 7B-3J[
M$AXN/S7Z5I>D.Z_:K.$XN;W>C^_TK7QB;&]L8/9'^+NE:^$39VMC![H_QETK
M7PA3]X:;0G?_ !CI6NC81@#-;!Y:P "6^/S/D_QG2M=17D?$L.\SR?XWI6NH
MQQ[P#Z^(?XV*F&0T@DT'$&6P#V/_ #W_ /_:  P# 0 "$0,1   0
M
M
M
M
M
M                                                       #>'
M                         "BS     _NMMN
M    'YM_(?J%:*J")[@                          =]MMM%MMYMI.
M                        %5=MMUMMLJ#H
M    % ,N5MMJ'                                *EMMM90
M                          =MM@  .VVX.VQ'VVH!0 . 66
M     -ML8  MMMPUMN&MM=%4 I#-N               -MI   K=# W;>&;9
MJ%J I3NL0              -MH    %0 QDD&$DD%% IP[
M  -M4    %0 UMN&MMK%Q.I'U7               -M     %0 S;;&+00%V
M)I K58              -M(    %0 Q  &8%(%PEA0X3P              -
ML     %0 S '&8&$%P$I%,T(              -L     '( O_\ 0J , "!&
MQ?[0              #;@                                    #6
M                                    #2       !(%$@(, !@(-$@@
M               #2       !,   H@(I,)(I)                #
M     )  ) (! !!((                #P
M            +P
M
M
M
M
M
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M;P+1-,%]6)%2"(R4# ;3Q(A$P$/T1!)?='$VLD M(MBF  M34*DE"KQ57^W
MKU\9P*:.7K'CD%2XZT>$[4ER;(#C[=P-J^P>"_ZA3JH"258L@I9RFM[ZGQ+[
M/.#D-[KWJ-.I.[0;HZJ]93SX @G@D03@&HW P&=$/)9HN<G;4DT!3/H9G0*D
M&G(S9TD9!!Q_HH%?OD_M+Q]G4A'C @0$2R(@>$U>BE)'ACZA)&C#R %0&*=Q
M X4W-9Y"B[SO!?66_=J2GZKY,J6L&A>9]N_J?$OL\X.0P"258D I91K>D;5]
M@\$_U*G7+]U[A CAI^R$P@,A5 (8O-V]"%G?![2,6D\^1Q(03Z$@6]/, @_
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M3Y^B'IMB[1C=X&#.O&] *0;2@R /ZQ"JKINCE>F66FY]M2L;L"O<R'0T#8(
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tern-20241114.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-11-18T16:08:23.4213+00:00 -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.ternspharma.com/20241114" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:tern="http://www.ternspharma.com/20241114" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tern-20241114.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46210743518800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Terns Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1448275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1065 East Hillsdale Blvd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">525-5535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TERN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( .2!<EF7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ Y(%R63JJHN=  0
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M?P%02P$"% ,4    " #D@7)9!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .2!<EDUL-9.[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( .2!<EF97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ Y(%R60,[(7O"!   FA(  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( .2!<EF?H!OPL0(  .(,   -              "  04-  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ Y(%R69>*NQS     $P(   L
M ( !X0\  %]R96QS+RYR96QS4$L! A0#%     @ Y(%R63JJHN=  0  / (
M  \              ( !RA   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M .2!<EDD'INBK0   /@!   :              "  3<2  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .2!<EEED'F2&0$  ,\#   3
M              "  1P3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  &84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tern-20241114.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tern-20241114.htm">tern-20241114.htm</File>
    <File>tern-20241114.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tern-20241114.htm": {
   "nsprefix": "tern",
   "nsuri": "http://www.ternspharma.com/20241114",
   "dts": {
    "inline": {
     "local": [
      "tern-20241114.htm"
     ]
    },
    "schema": {
     "local": [
      "tern-20241114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_8b6685cf-6edc-4cc2-b6c0-f721004e3624",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20241114.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8b6685cf-6edc-4cc2-b6c0-f721004e3624",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tern-20241114.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ternspharma.com/20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-24-127964-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-127964-xbrl.zip
M4$L#!!0    ( .2!<EEG;I ?W18  +^X   1    =&5R;BTR,#(T,3$Q-"YH
M=&WM/6MSXL:6W_,K^CJ[B:?6#7H_L&=N.=B3L)FQ78;43>V75$O=,KHC)"()
M&^ZOWW-:$@@;_ 0;QDRJ8B3UZYP^[S[=??3/\2 BUR+-PB3^^+/:4'XF(O83
M'L97'W\^[K8[G9__^>F'HW]02DX^=\[(F;@AQWX>7HN3,/.C)!NE@NQWOWX@
MG3@*8T'^_.7R"SE)_-% Q#FAI)_GPU:S>7-ST^!!&&=)-,JAKZSA)X,FH;1L
MO)T*AN_)"<L%:6F*9E!5I:K34ZV6XK0TO:%8BO(_BM)2E%JU9#A)PZM^3O;]
M#P1K0=]Q+*)(3,CG,&:Q'[*(=*M>#V"8?H,<1Q&YQ&H9N1292*\%;Q2-]G/
M!^ DSC[NU89^HS>2]*JINJ[;'&.9O:)0:^RE$0^G9?%1EM04Q6H6'^>*Y@N+
MFD71O%XTG!M O;3>!#SF )JHR@/FO]U3'#][+)L6']\I/P<??JV*AN-E[:HX
M#)QRG/&J>)S$9S#S:>@OKL;SM)E/AJ()!6E<E)R.*@L7C0D@4)M_?OW2]?MB
MP.AMT+FXA?U,^(VKY+H)'YI($%7!7*3Q7/OX(AOV63I@DABQL*JJQ@STG$)C
M<W6JQF>0-_.4Q5F00"M(88@8DRH.U=5:.XN1<5\CFD85C:K6WJ<?R%%?, Y_
MR5$>YI'XY-#?CYK%3WPY$#F3;$;%WZ/P^N->.XES8#[: T3O$;]X^KB7BW'>
ME+3;Q$:;9:M'7L(G),LGD?BX-V#I51BW"!OER3_"P3!) =GYX9!QE @MX@S'
MASAHVA?(/BVB'N[)0?#PNFJ#A]DP8A.D!0%?C\)Q"[L2:?$SY%S$\N>,6$C(
M/^Y]_DLW&;=M6U#',SQJ!+9!75^85&7<M&W#\36;[9&8#; 7$;9.8\#"I W0
MI2SJQ%R,?Q>3$N)Q?BD"P,5?CF=9CND'U!+<IX;O:]2S?(4&MJ8JBB%T"VCD
MDP)4YNBJ;NE'S;FA+1ZIH3+#$XI++68%U#!LBSJ&9U >>*IEF(%K>%I]I,<@
M#3E*Q,\1NWK>" ,69>+.X)KS*$U%(%(0X"+[=(1LW,HDUT!'1+)U"YGOXUX&
M4QLA"\EW_13'@>Q *QYHC#,.9"*;K[<I'[-DE,HG*:9:)3 2,X\%IJPJY 16
M3R''YR 4*9'#%@M9K]WY?7ZZ;E?^5+V:;WT("$MX]01"),U1UWR:JAJCJC?[
M-ATF7U*T^E(]5YTTYU!3X7&*N&:-)YK .K=9Z#\@YH":6U0_'(1QQ6Q*PPSC
MPV&2A2@DH+V(H2)&'ILV,JR:\)(4FJ=Y,FQI#<T<YH0G(R\2Y$=%_CL,8&PT
M"_\C6JHRS \+SI?ERV\!&X31I-4+!R*3>O\R&;"X*N@E>9X,H"P"2%D47L6M
M2 0YCB8;LK@:QTT_S 6%-[YH#5-!;U(VO-WWO=U!7S<AS_NM(,QI*<R@DY]^
M5"WE\*B)?0'\PWGHEP-G-FSSH2Z70^A#YR*]#:.?1$G:JA"['.*;8AZ]).)U
M%#C/1,$?9YW>Z0GI]HY[I]TC+VU^ZIZV_[CL]#JG77)\=D)._VS_=GSVZREI
MGW_]VNEV.^=GLEB%M17"H#T3AG\==W_KG/W:.S\[(">-=@-L.--PETUK.3-(
M9RU#^>^5T7#)+-6S)!$"IFK(I^Q25I'&INQ[R^C^X0ZWA.H_GU]^)8LH^ EM
M[RW6ZMR%_W3?HZYE,6H(0Z>NQ@5EG-FFZ2K",KUG*>^:)5"Y1M(XVPB$2G.R
M)*?;UL6.#5?,ANZ&<>%SY3;HF<O3LQZY/+TXO^RM&P\6E-Y43%R,TFP$3A+)
M$](5O@QBJ#I)4J*:^_P#20*2]P5^&J5@N$&;IV._S^(K@8$4_*RZNG$+@SE#
M4VW>E$-8T D#HL"O%'RL9)3#:,:"'Q8C XG3 )XH*P!"(C;,1"L30Y:"F5KX
M:M!Z6C5]'6:A%T9@)K>JTF4A*,6G3%0UCDV/$5\XCA(%,$?C0^E20AUP9&]W
M41JOD@ 63LH-C)9ZJ6#?6O+_%%\LX.O;HRJ=TD+.-!05;.-KD>:ASZ*R(GRI
M7-<I1X52^C^"0I\FNN;D$HQ&<QU+K?V#;M="P,NH4H;1@+8N!?KP9+]Z%@S\
M$I'E1%QC?"Z5GP7_T)I3J4O4H\=M 4X7]54=W'.N:I0)WZ6Z:YD\\ -+#9Q5
MJ<<+Z4B=%N[5'BE"(Q_WPG'>XO"&#J"7/E:CG$WH!,"B(EXC/L^2:S'PP#-5
MC0,99WQ890(S\#FN@+_(N,_5I4]U6]Z!-OV^/=55FPJSKC3C>0:RYRJ^H[C
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M;\U-FN6:JB(,RKCO4<,+/.IYED,UPU,=YKN.HZY6PK7AYWG:2V[6&4G\G&0
M.<&^'N"F=8W@X!'I$<)CKF4$-M5L7:,&R"[J:IY!'=\+5,]23.&L*.A7XEY&
M!<[3BS2Y#N6.F+>+];:!1*'W.&3?68CPT4M@Z[9AB\%MB1@R#$.XMN=0U[#!
MT%*X0STP4JCN&:JEVMRUS-6RP@5("!;]7SB4BQYKC)@:AO*<U)]=L/3U@E4E
M26#6P44*@C$<LHB<CH4_PMTRY#P(0E]DKQWOVPZC:Q?P+&@() E!47)O5'-A
M/M\N#6.7C:PT5,W<I2/7R&J6_O73CXZFVH<9Z8E(#/M)7"W R$2Z:(38(<>
M><E_K6<:]LO&\0@SWO:88[LNI[;0&#5T5:%, 1>*NZ;/'"%LW3)>:KN@)X,P
MKME:V;=,Y<-J/:87(-8T/,W7A*#<<, _<DR',MLRJ.U: ?=]IKGJBU?2OR3
M;A=(56M?/#<UDYJF_IRE\YWBV"F.#54<3W3T+,5T3-,(J&8&!B8ZF<"?@4,5
MH9JVIG!#T>Q5I;E-C\?X##]$^D5<L>@\+32+2 5?4:+X\AT@.3D>#B.8%R#;
M#>;Z#<L#+V:+G,E$\)24CZ63=D#" )._XRO!21>C6.0+KF,4VY96D0[>T'?[
M9EZ.E5L;,!?!^%@">QG$[;[PO\D-E6PX3)-A&F)F%,ANXHDHN4%RPH](9<2A
MOY, M (8E&%&0FR" YGE"<G"P2C*62R2419-2 9B)0LFLF99(?$ T"*YI=S
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M$H(!'PTPN/KY2[V>[50(2!!@@A"T 2TY)VA+(2L0 X8/P/I5Q&;1=NPY#@B
MZB==ZAEMIR,%G9CC804-K5O5K*1ME49UO %!+<"OALN-*P*\IOH5IQVH[93%
M6 V1+["DME/!0$$:M8'YE;6N-I3@PP ?IP'2ZTRL#44P6,5,X(( & 3(P(=N
M4%8-@II2DO7"-N3OEP5D"C3]U>0U$*A-,$_:9!NR%U! 8-6^..4MM$VI1T!
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M,C R-#$Q,30N:'1M4$L! A0#%     @ Y(%R6>L4Q4?]"   9FD  !$
M         ( !#!<  '1E<FXM,C R-#$Q,30N>'-D4$L! A0#%     @ Y(%R
M63"EMU[]#0  LCP   \              ( !."   '1E<FXM97@Y.5\Q+FAT
7;5!+!08      P # +L   !B+@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tern-20241114_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tern-20241114.xsd" xlink:type="simple"/>
    <context id="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831363</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_35ad777e-8b4b-4f74-9ce5-1ad57748c27a">0001831363</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_41a4be09-6a6f-4476-84b4-dfb1645f94b2">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_d9d9d3cb-966a-4e43-92de-ada75590e65b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_dbd7e313-c13b-4d12-aec9-3965dfcf61f8">2024-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_b90c8090-f8e2-42bf-81e7-f55ce2757df2">Terns Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_70cbbacf-d787-40bb-803f-c171e05536cc">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_cd786709-c362-4a96-9081-1f30f1a10ae8">001-39926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_3e50b778-10d1-4ec8-b4cd-7bc2080dbb75">98-1448275</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_5ca26a61-d15f-47c6-8d95-a24c131002d2">1065 East Hillsdale Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_5afdbad6-1af0-4e39-8ebd-685169626166">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_269510e4-adcb-4bfb-bb68-24b18ac98812">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_eba964f7-2732-4962-92b4-8cbf1b605e88">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_444e97b8-947f-40d8-b106-3b41617d9658">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_7ba8799d-7e2a-4310-a068-d95ca8ee7364">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_54b2c2ee-d482-4858-a764-796fdcca2915">525-5535</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_6058554f-25f4-4a95-b6f8-0e15720d4027">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_68445042-42ab-4466-9cff-c6ac5018aa6a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_cea236c7-d9cb-4a67-9fc8-8589da270418">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_debe4bb7-8117-41db-a328-77dd38fe322d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_a01903ff-a599-4b9f-9c2b-740857f7e77b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_12e9ccf6-dea3-4f4d-a2d4-073a9ee2c7df">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_58ec0c33-cd4b-4d19-b171-774ae6eeb5f3">TERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_6c931630-d568-4844-a0ed-923b6484ac71">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_106cd42a-4954-4884-8366-31f95e6cfc09">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_8b6685cf-6edc-4cc2-b6c0-f721004e3624"
      id="F_434d00bf-20b7-49b6-9dc0-19e6f7e09c01">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
